Literature DB >> 3081933

Hormonal and behavioral effects associated with intravenous L-tryptophan administration.

A Winokur, N D Lindberg, I Lucki, J Phillips, J D Amsterdam.   

Abstract

Doses of 5.0, 7.5 and 10.0 g L-tryptophan, the amino acid precursor of serotonin, or saline alone were administered by IV infusion to a group of 11 healthy male subjects, and both hormonal and behavioral responses were monitored. Significant increases were observed in plasma concentrations of growth hormone and prolactin after all three doses of L-tryptophan, but not after saline infusion. No alterations in cortisol or thryotropin were noted at any level. Examination of behavioral effects of L-tryptophan revealed a dose-dependent impairment in performance on the symbol copying test. In addition, L-tryptophan produced significant effects on mental and physical sedation, but did not alter subjective ratings of tranquilization. In agreement with some prior reports, these observations support the ability of L-tryptophan, when administered IV in high doses, to produce pronounced effects on the central nervous system in humans, and suggest the potential utility of this paradigm as a neuroendocrine challenge test.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081933     DOI: 10.1007/bf00652243

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion.

Authors:  P D Woolf; L Lee
Journal:  J Clin Endocrinol Metab       Date:  1977-07       Impact factor: 5.958

2.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects.

Authors:  E D Weitzman; D Fukushima; C Nogeire; H Roffwarg; T F Gallagher; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

3.  Lack of effects of L-tryptophan on basal and TRH-stimulated TSH and prolactin levels.

Authors:  J Faber; C Hagen; C Kirkegaard; U B Lauridsen; S E Møller
Journal:  Psychoneuroendocrinology       Date:  1977-10       Impact factor: 4.905

Review 4.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

5.  5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.

Authors:  H M van Praag; J Korf; J Puite
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

Review 6.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

7.  Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.

Authors:  I Lancranjan; A Wirz-Justice; W Pühringer; E Del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

8.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

9.  Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder.

Authors:  D S Segal; R Kuczenski; A J Mandell
Journal:  Biol Psychiatry       Date:  1974-10       Impact factor: 13.382

10.  Absent prolactin response to L-tryptophan in normal and acromegalic subjects.

Authors:  A R Glass; R C Smallridge; M Schaaf; R C Dimond
Journal:  Psychoneuroendocrinology       Date:  1980       Impact factor: 4.905

View more
  3 in total

1.  Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.

Authors:  M Koulu; M Scheinin; A Kaarttinen; J Kallio; K Pyykkö; J Vuorinen; R H Zimmer
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites.

Authors:  G Heuther; G Hajak; A Reimer; B Poeggeler; M Blömer; A Rodenbeck; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications.

Authors:  Dawn M Richard; Michael A Dawes; Charles W Mathias; Ashley Acheson; Nathalie Hill-Kapturczak; Donald M Dougherty
Journal:  Int J Tryptophan Res       Date:  2009-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.